Changes in the levels of inflammatory infiltrations could be genotype‐dependent (i.e. changes in signalling by FGFR3 mutant proteins may have regulated the level of inflammation) or, alternatively, phenotype‐dependent (i.e. the inflammatory phenotype may have been caused by the severity of bladder/tumour pathology). Here, FGFR3 is linked to neoplasm.